Related Experiment Video
Updated: Apr 3, 2026

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
Phenotypic Characterization of Insulin-Resistant and Insulin-Sensitive Obesity
D L Chen1, C Liess1, A Poljak1
1Division of Diabetes and Metabolism (D.L.C., A.B.J., D.J.C., D.S.-B., J.R.G.), Garvan Institute of Medical Research and Bioanalytical Mass Spectrometry Facility (A.P.), School of Medical Sciences (A.P., D.S.-B.), Center for Healthy Brain Ageing (A.P.), and Faculty of Medicine (J.R.G.), University of New South Wales, and Department of Radiology (B.M.), and Department of Endocrinology and Diabetes Center (J.R.G.), St Vincent's Hospital, Sydney, New South Wales 2010, Australia; Philips Healthcare (C.L.), Luebeckertordamm 5, 20099 Hamburg, Germany; State Key Laboratory of Pharmaceutical Biotechnology (A.X., J.Z.), University of Hong Kong, Hong Kong; Movelab (C.T., M.T.), Newcastle University, Newcastle-upon-Tyne NE1 7RU, United Kingdom; and School of Health Science (A.B.J.), University of Wollongong, Wollongong, New South Wales 2500, Australia.
Insulin sensitivity in muscle or liver in obese individuals is linked to better metabolic health, including lower blood pressure and reduced visceral fat. This study identifies key factors contributing to insulin sensitivity in obesity.
Area of Science:
- Metabolic research
- Obesity studies
- Endocrinology
Background:
- Obesity and insulin resistance frequently coexist.
- However, some individuals with obesity maintain insulin sensitivity.
- Understanding this variability is crucial for metabolic health.
Purpose of the Study:
- To investigate phenotypic and metabolic factors associated with insulin sensitivity in muscle and liver among obese individuals.
- To identify protective factors against insulin resistance in obesity.
Main Methods:
- Sixty-four non-diabetic obese adults underwent hyperinsulinemic-euglycemic clamps.
- Muscle and liver insulin sensitivity were assessed using glucose infusion rate and endogenous glucose production suppression.
- Clinical parameters, including body composition and fat distribution (visceral, subcutaneous, liver, pancreatic), were measured.
Main Results:
- Individuals with muscle insulin sensitivity (Musclesen) had lower glycated hemoglobin and blood pressure, despite similar body mass index and total fat compared to insulin-resistant counterparts (Muscleres).
- Musclesen also exhibited lower visceral and liver fat.
- Insulin sensitivity in either muscle or liver conferred protection against adverse metabolic features.
- Factors like HDL-cholesterol, 1-hour glucose, systolic BP, and triglycerides explained 54% of the variance in muscle insulin sensitivity.
Conclusions:
- Obese individuals with insulin sensitivity in muscle and/or liver display favorable metabolic profiles, including reduced blood pressure and adiposity.
- This research highlights specific factors contributing to insulin sensitivity in the context of obesity.
- Maintaining insulin sensitivity is associated with better overall metabolic health in obese populations.
Related Concept Videos
Obesity
Insulin: The Receptor and Signaling Pathways
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug Dosing: Obese Patients
Diabetes: Symptoms, Diagnosis, and Complications

